Search the Newsreel

EMBC Shareholder Alert: August 17, 2026 Lead Plaintiff Deadline in Embecta Corp. Securities Class Action - Contact The Gross Law Firm

The Gross Law Firm has issued a shareholder alert regarding a securities class action against Embecta Corp. (NASDAQ: EMBC). Shareholders who purchased EMBC shares between November 25, 2025, and May 4, 2026, are encouraged to contact the firm, as the company is accused of …

Embecta (EMBC) Q3 2026 Earnings Call Transcript

Insider Spends US$141k Buying More Shares In Embecta

Embecta's President, Devdatt Kurdikar, recently purchased US$141k worth of company stock at US$4.70 per share, increasing his holding by 3.9%. This is the largest insider purchase in the last year, suggesting optimism for the company's future, despite the overall insider ownership being relatively low …

Embecta Corp. SVP Elguicze purchases $93,360 in common stock

Embecta Corp.'s Senior Vice President and CFO, Jacob Elguicze, recently purchased 20,000 shares of the company's common stock for $93,360. This insider purchase comes after a significant stock decline but a recent rebound, with the company trading at a low P/E ratio. The purchase …

Kaplan Fox Continues to Alert Investors of Embecta Corp. (NASDAQ: EMBC) to a Class Action Deadline on August 17, 2026

Kaplan Fox & Kilsheimer LLP is alerting investors of Embecta Corp. (NASDAQ: EMBC) about a class action lawsuit filed against the company. The lawsuit, on behalf of investors who purchased securities between November 25, 2025, and May 4, 2026, alleges that Embecta misrepresented its …

EMBC Deadline: Rosen Law Firm Urges Embecta Corp. (NASDAQ: EMBC) Stockholders to Contact the Firm for Information About Their Rights

Rosen Law Firm has issued a reminder to investors regarding a class action lawsuit against Embecta Corp. (NASDAQ: EMBC). The lawsuit alleges that Embecta made misleading statements about its fiscal results and its pen needle business, causing investors to suffer damages. Shareholders who wish …

Embecta director Robert Hombach acquires $223.8k in common stock

Embecta director Robert J. Hombach recently acquired 45,000 shares of the company's common stock for a total of $223,848. This insider purchase comes as the stock has seen a 36% surge in the past week, despite being significantly down from six months ago. The …

Embecta Corp. (EMBC) CFO purchases 20,000 shares in open-market trade

Embecta Corp.'s Senior Vice President and CFO, Jacob Elguicze, purchased 20,000 shares of the company's common stock on August 12, 2026, at a price of $4.668 per share. This open-market transaction increased his direct holdings to 309,138.604 shares. The purchase was not made under …

EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit with SBS Law

Schall, Brown & Schwartz LLP (SBS) has reminded investors of a class action lawsuit against Embecta Corp. (EMBC) for alleged violations of securities laws. The lawsuit claims Embecta made false and misleading statements regarding its fiscal guidance for Q2 and full-year 2026, failing to …

Sembcorp (SGX:U96) Stock Grapples With Revenue Growth And Thinner Margins

EMBECTA CORP. INVESTORS WITH LOSSES HAVE UNTIL AUGUST 17,

Bernstein Liebhard LLP reminds Embecta Corp. (NASDAQ: EMBC) investors that they have until August 17, 2026, to join a securities fraud class action lawsuit. The lawsuit alleges that Embecta made false and misleading statements about its business operations and financial stability between November 25, …

EMBC 6-DAY DEADLINE ALERT: Embecta Corp. Investors with

Hagens Berman is investigating Embecta Corp. (NASDAQ: EMBC) for alleged federal securities law violations after a class action lawsuit was filed. The lawsuit claims Embecta misrepresented the stability of its insulin pen needle business, leading to substantial investor losses. Investors who suffered losses between …

EMBC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Embecta Corp. to Contact the Firm Today!

Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Embecta Corp. (NASDAQ:EMBC) and its officers for alleged federal securities law violations. The firm encourages investors who purchased Embecta securities between November 25, 2025, and May 4, 2026, to contact them, as …

Deadline Alert: Embecta Corp. (EMBC) Shareholders Who Lost

Glancy Prongay Wolke & Rotter LLP has issued a deadline alert for investors of Embecta Corp. (EMBC) who suffered losses. Shareholders who purchased securities between November 25, 2025, and May 4, 2026, are urged to contact the firm regarding a securities fraud lawsuit, with …

Embecta Corp. (EMBC) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Glancy Prongay Wolke & Rotter LLP has announced a securities fraud class action lawsuit against Embecta Corp. (EMBC), urging investors who suffered losses to come forward. The lawsuit alleges that Embecta made misleading statements between November 25, 2025, and May 4, 2026, regarding its …

EMBC Investor Announcement: Embecta Sued on behalf of Investors to Recover Losses after Insulin Pen Issues Lead to 57% Stock Drop

A class action lawsuit has been filed against Embecta Corp. (NASDAQ: EMBC) and its executives for securities fraud. The lawsuit alleges that Embecta misled investors about the strength of its insulin pen needle product category, leading to a 57% stock drop after disappointing Q2 …

Kaplan Fox Encourages Investors of Embecta Corp. (NASDAQ: EMBC) to Contact the Firm Before Lead Plaintiff Deadline on August 17, 2026

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against Embecta Corp. (NASDAQ: EMBC) on behalf of investors who purchased securities between November 25, 2025, and May 4, 2026. The lawsuit follows a significant drop in Embecta's stock price after the company …

EMBC Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Embecta Corp. Securities Lawsuit - Contact The Gross Law Firm

The Gross Law Firm has issued a shareholder alert for investors of Embecta Corp. (NASDAQ: EMBC) who purchased shares between November 25, 2025, and May 4, 2026. The lawsuit alleges that Embecta made misleading statements regarding its fiscal results, specifically its pen needle business, …

Embecta Corp. Notice of August 17, 2026 Application Deadline for Class Action Lawsuit - Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP Before Application Deadline

Hagens Berman, a national shareholder rights law firm, is investigating Embecta Corp. (NASDAQ: EMBC) for alleged violations of federal securities laws after a class action lawsuit was filed. The lawsuit claims Embecta misrepresented the stability of its insulin pen needle business, leading to a …

EMBC INVESTOR ALERT: Embecta Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Hagens Berman is investigating Embecta Corp. (NASDAQ: EMBC) for alleged violations of federal securities laws, following a class action lawsuit claiming Embecta misrepresented the commercial stability of its insulin pen needle business. The lawsuit alleges the company's statements about its "stable" and "resilient" pen …

Embecta adds to earnings rally with another 9% advance (EMBC:NASDAQ)

Embecta Corp. (EMBC) shares climbed another 9% on Monday, extending a rally initiated by the medical device company's strong quarterly earnings release. This surge brings the total rally to over 26% since the previous session, driven by better-than-expected non-GAAP EPS and revenue, and raised …

Embecta Q3 results beat analyst expectations

Embecta Corp. (Nasdaq: EMBC) reported Q3 results that surpassed analyst expectations, leading the company to raise its full-year adjusted earnings per share outlook. The medtech firm, specializing in insulin delivery, posted net income of $21.1 million on $271.7 million in revenue, with adjusted EPS …

Kaplan Fox & Kilsheimer LLP Alerts Embecta Corp. (NASDAQ: EMBC) Investors to a Securities Class Action Deadline on August 17, 2026

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against Embecta Corp. (NASDAQ: EMBC) on behalf of investors who purchased securities between November 25, 2025, and May 4, 2026. The lawsuit alleges that Embecta's management knew or recklessly disregarded weaknesses in the …

Embecta Number of Employees 2026 | Employee Count & Headcount Data

Embecta Corp. (EMBC) had approximately 1,829 employees worldwide as of March 2026, representing a 14.7% decline from 2023. Despite the overall headcount reduction, Embecta is actively hiring, with 143 active job postings in 2026, a 43.4% increase from 2025. The company's workforce is primarily …

EMBC|Embecta Corp|Price:4.420|Chg%:+0.920

Embecta (EMBC) Stock Jumps On Profit Rebound Despite Lingering Debt Strain

EMBC Deadline: EMBC Investors with Losses in Excess of $100K Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit

The Rosen Law Firm is reminding investors who purchased Embecta Corp. (NASDAQ: EMBC) common stock between November 25, 2025, and May 4, 2026, of the August 17, 2026, lead plaintiff deadline for a securities fraud lawsuit. The lawsuit alleges that Embecta made false and …

Embecta forecasts $1.80-$1.90 FY2026 adjusted EPS while raising adjusted operating margin to 23.5%-24%

Earnings Call Insights: Embecta (EMBC) Q3 fiscal 2026 MANAGEMENT VIEW * "During the third quarter, Embecta generated total revenue of approximately $272 million" and "on a sequential basis, our third quarter financial performance improved significantly with revenue increasing approximately $50 million" (President, CEO & …

Embecta Corp. 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:EMBC) 2026-08-07

Embecta Corp (EMBC) reported a strong sequential recovery in Q3 fiscal 2026, with revenue increasing by approximately $50 million and adjusted operating income rising by about $21 million compared to Q2. The company raised its fiscal 2026 adjusted operating margin guidance to 23.5%-24% and …

EQUITY ACTION ALERT: Faruqi & Faruqi, LLP Reminds Embecta (EMBC)

Faruqi & Faruqi, LLP is reminding Embecta (EMBC) investors of the August 17, 2026 deadline to seek lead plaintiff status in a securities class action lawsuit. The lawsuit alleges that Embecta made misleading statements regarding its financial guidance, particularly its pen needle business, which …

Embecta Corp (EMBC) (Q3 2026) Earnings Call Highlights: Strong Sequential Recovery and Raised ...

Embecta Corp (EMBC) reported a strong sequential recovery in Q3 fiscal 2026, with revenue increasing by approximately $50 million and adjusted operating income rising by about $21 million compared to Q2. The company raised its fiscal 2026 adjusted operating margin guidance to 23.5%-24% and …

EMBECTA DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Embecta Corp. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 17 Deadline in Securities Class Action – EMBC

NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Embecta Corp. (NASDAQ: EMBC) between November 25, 2025 and May 4, 2026, inclusive (the “Class Period”), of the important August …

Embecta Corp. (Nasdaq: EMBC) Q3 2026 profit slides on revenue decline

Embecta Corp. (EMBC) reported a significant decline in Q3 2026 profits and revenue, with net income falling 53.6% to $21.1 million and revenue decreasing by 8.1% to $271.7 million, largely due to lower pricing and volumes. The company completed the $208.0 million acquisition of …